These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13904008)

  • 21. [Comparative study of the clarifying activity in vitro of serum after the addition of various heparinoid substances].
    WOLFF R; BRIGNON JJ
    Arch Int Pharmacodyn Ther; 1959 Sep; 121():255-67. PubMed ID: 13845713
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of deoxyribonucleic acid and heparinoid compounds on nucleic acid metabolism of the mouse].
    Tempel K
    Z Naturforsch B; 1969 Dec; 24(12):1550-5. PubMed ID: 4189413
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of heparin on various polysaccharide-protein structures: relation to the clearing factor].
    CENCIOTTI L; MARIOTTI A; ZANELLI P
    Boll Soc Ital Biol Sper; 1959 Oct; 35():1198-202. PubMed ID: 13808768
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the fibrinolytic effect of heparin and heparinoids].
    Naegeli T; Matis P
    Zentralbl Chir; 1965 Jun; 90(23):881-3. PubMed ID: 4157844
    [No Abstract]   [Full Text] [Related]  

  • 25. [RESEARCH ON THE FIBRINOLYTIC AND ANTICOAGULANT ACTION OF A SULFURATED DERIVATIVE OF XYLAN (SYNTHETIC HEPARINOID) WITH A LOW-GRADE POLYMERIZATION].
    CIPOLLI PL; GIBELLI A
    Riv Patol Clin; 1963 Aug; 18():395-403. PubMed ID: 14083551
    [No Abstract]   [Full Text] [Related]  

  • 26. [The increase of thrombin inhibitor in the blood after percutaneous administration of a heparinoid].
    WITTE S; BRESSEL D
    Klin Wochenschr; 1960 May; 38():501. PubMed ID: 13845470
    [No Abstract]   [Full Text] [Related]  

  • 27. [CONTRIBUTION TO THE MANAGEMENT OF VENOUS THROMBOSES AND THROMBOPHLEBITIS].
    ZAWODSKY L
    Wien Med Wochenschr; 1964 Jul; 114():525-9. PubMed ID: 14236494
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of a heparinoid extract on the total serum cholesterol and the alpha and beta lipoprotein fractions].
    MANCINI M; D'ANDREA L; ORIENTE P; GUERRIERI R; MAIORANO G
    Minerva Med; 1960 Feb; 51():389-91. PubMed ID: 14420509
    [No Abstract]   [Full Text] [Related]  

  • 29. [EXPERIMENTAL ANIMAL STUDIES ON PERCUTANEOUS THROMBOLYSIS WITH A NEW SYNTHETIC HEPARINOID OINTMENT].
    JESTAEDT R; SCHLUETER G
    Med Welt; 1964 Feb; 6():297-9. PubMed ID: 14140212
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of a natural heparinoid with sodium and calcium heparin for their effect on the inhibitor of activated factor X.
    Mannucci PM; di Santo C; Franchi F
    Experientia; 1976 Nov; 32(11):1478-80. PubMed ID: 62674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [COMPARISON OF SOME EFFECTS OF HEPARIN AND THE PERORAL HEPARINOID "ATEROID" IN RATS].
    CEPELIK J; CERNOHORSKY M
    Cas Lek Cesk; 1963 Nov; 102():1291-4. PubMed ID: 14111755
    [No Abstract]   [Full Text] [Related]  

  • 32. Polysaccharide polysulphuric acids as antihyaluronidases.
    ASTRUP T; ALKJAERSIG N
    Nature; 1950 Sep; 166(4222):568-9. PubMed ID: 14780152
    [No Abstract]   [Full Text] [Related]  

  • 33. Heparinoid and heparin; an investigation into the anticoagulant effect of the dextran sulphate dexulate.
    ARGE E
    Acta Med Scand; 1956 Nov; 155(6):469-74. PubMed ID: 13372201
    [No Abstract]   [Full Text] [Related]  

  • 34. EFFECT OF HEPARIN AND HEPARINOIDS ON THE SYNTHESIS OF ALDOSTERONE AND CORTICOSTERONE BY THE RAT ADRENAL GLAND.
    GLAZ E; SUGAR K
    Endocrinology; 1964 Feb; 74():159-64. PubMed ID: 14122519
    [No Abstract]   [Full Text] [Related]  

  • 35. [Esterolytic activity of serum following administration of heparinoid].
    PLACER Z; SLABOCHOVA Z; ROUBAL Z
    Cesk Fysiol; 1959 Apr; 8(3):236-7. PubMed ID: 13671575
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on the mechanism of heparin action on blood clotting and fibrinolysis].
    NIEWIAROWSKI S; WEGRZYNOWICZ Z
    Pol Tyg Lek; 1961 Jun; 16():901-5. PubMed ID: 13729010
    [No Abstract]   [Full Text] [Related]  

  • 37. [HEPARINOIDS--PHYSIOLOGICAL PROPERTIES AND THERAPEUTIC INDICATIONS].
    GUILLEMAN P; HARDY N
    Rev Prat; 1964 Oct; 14():3391-405. PubMed ID: 14205831
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect in man of a new heparinoid, treburon.
    FIELD JB; RAMSAY GD; ATTYAH AM; STARR P
    J Lab Clin Med; 1953 Feb; 41(2):208-14. PubMed ID: 13035252
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of heparan sulphate and other glycosaminoglycans binding to Helicobacter pylori by various polysulphated carbohydrates.
    Hirmo S; Utt M; Ringner M; Wadström T
    FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):301-6. PubMed ID: 7539671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxicology of synthetic polysaccharide polysulphuric acid esters.
    PIPER J
    Acta Pharmacol Toxicol (Copenh); 1946; 2(4):317-28. PubMed ID: 20295476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.